Literature DB >> 9018796

A structural model for 30 Rh D epitopes based on serological and DNA sequence data from partial D phenotypes.

M L Scott1, D Voak, J W Jones, N D Avent, W Liu, N Hughes-Jones, H Sonneborn.   

Abstract

Both cDNA RHD sequences and reactivity with monoclonal anti-D have been reported in a number of partial D phenotypes, where parts (some epitopes) of the normal D antigen are missing, and anti-D of restricted specificity may be made in response to challenge with normal D positive blood. This paper analyses these reports together and proposes a model for the structure which comprise the epitopes of the Rh D antigen. Some epitopes are proposed to be comprised of continuous peptide sequence within one extracellular loop, whereas others require interactions between two or the extracellular peptide loops.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9018796     DOI: 10.1016/s1246-7820(96)80051-6

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  4 in total

1.  A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.

Authors:  Patrick T McGann; Jenny M Despotovic; Thad A Howard; Russell E Ware
Journal:  Am J Hematol       Date:  2011-11-25       Impact factor: 10.047

2.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

3.  D category IV: a group of clinically relevant and phylogenetically diverse partial D.

Authors:  Inge von Zabern; Franz F Wagner; Joann M Moulds; John J Moulds; Willy A Flegel
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

Review 4.  Application of genomics for transfusion therapy in sickle cell anemia.

Authors:  Stella T Chou; Connie M Westhoff
Journal:  Blood Cells Mol Dis       Date:  2017-08-08       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.